Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019

…, H Wang, W Liu, X Liao, Y Su, X Wang… - Clinical infectious …, 2020 - academic.oup.com
Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody
response in infected patients remains largely unknown, and the clinical value of antibody …

Treatment of 5 critically ill patients with COVID-19 with convalescent plasma

C Shen, Z Wang, F Zhao, Y Yang, J Li, J Yuan, F Wang… - Jama, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic
agents and substantial mortality. It is critical to find new treatments. Objective To determine …

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

…, C Zhang, F Huang, F Wang, J Yuan, Z Wang… - Science China Life …, 2020 - Springer
The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei province,
and rapidly spread to many provinces in China as well as other countries. Here we report …

[HTML][HTML] Experimental treatment with favipiravir for COVID-19: an open-label control study

…, S Zhang, F Wang, J Liu, L Chen, S Chen, Z Wang… - Engineering, 2020 - Elsevier
There is currently an outbreak of respiratory disease caused by a novel coronavirus. The virus
has been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the …

Obesity and COVID-19 severity in a designated hospital in Shenzhen, China

…, T Wang, F Luo, X Liu, Q Wu, Q He, Z Wang… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE Patients with obesity are at increased risk of exacerbations from viral respiratory
infections. However, the association of obesity with the severity of coronavirus disease …

[HTML][HTML] Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020

…, J Yuan, F Wang, Y Liu, Z Wang, FS Wang… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Since early January 2020, after the outbreak of coronavirus infection in Wuhan, China,≈
365 confirmed cases have been reported in Shenzhen, China. The mode of community and …

Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19)

…, L Yu, Q Cao, B Ruan, L Liu, Z Wang… - Clinical infectious …, 2020 - academic.oup.com
Background An outbreak of coronavirus disease 2019 (COVID-19) is becoming a public
health emergency. Data are limited on the duration and host factors related to viral shedding. …

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections

…, C Shen, F Wang, J Yuan, J Li, M Zhang, Z Wang… - MedRxiv, 2020 - medrxiv.org
Background The outbreak of novel coronavirus pneumonia (NCP) caused by 2019-nCoV
spread rapidly, and elucidating the diagnostic accuracy of different respiratory specimens is …

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

…, X He, M Ou, J Bi, R Yang, W Di, Z Wang… - Emerging microbes & …, 2020 - Taylor & Francis
The dysfunction of the renin-angiotensin system (RAS) has been observed in coronavirus
infection disease (COVID-19) patients, but whether RAS inhibitors, such as angiotensin-…

[PDF][PDF] Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury

Y Liu, C Zhang, F Huang, Y Yang, F Wang… - National Science …, 2020 - academic.oup.com
A recent outbreak of pneumonia in Wuhan, China was found to be caused by a 2019 novel
coronavirus (2019-nCoV or SARS-CoV-2 or HCoV-19). We previously reported the clinical …